76-6.17). Gait variability also discriminates between different frailty status groups in particular during fast walking. find more Prominent parameters related to prefrailty are reduced cadence (d = 1.43) and increased step width variability (d = 0.64), whereas frailty (vs. prefrail status) is characterized by

reduced step length during habitual walking (d = 1.32) and increased double support during fast walking (d = 0.78). Interestingly, one study suggested that dual-task walking speed can be used to predict prospective frailty development. Conclusion: Gait characteristics in people with frailty are insufficiently analyzed in the literature and represent a major area for innovation. Despite the paucity of work, current results suggest that parameters beyond speed

could be helpful in identifying different categories of frailty. Increased gait variability might reflect a multisystem see more reduction and may be useful in identifying frailty. In addition, a demanding task such as fast walking or adding a cognitive distractor might enhance the sensitivity and specificity of frailty risk prediction and classification, and is recommended for frailty assessment using gait analysis. Copyright (C) 2013 S. Karger AG, Basel”
“Density functional calculations are presented for various properties of the elpasolite crystals Cs2NaYX6 (X= F, Cl, Br) using the CASTEP module, either in the generalized CCI-779 PI3K/Akt/mTOR inhibitor gradient approximation (GGA) or in the local density approximation (LDA). Specifically, the calculated properties are lattice parameter, density, band gap, elastic constants, bulk modulus, sound velocity, Debye temperature, Gruneisen constant, phonon frequencies and phonon dispersion. The variations of some of these properties with applied pressure have also been calculated. Comparison with experimental data is made where available. (C) 2013 Elsevier B.V. All rights reserved.”
“Mesenchymal

hamartoma of the chest wall (MHCW) is a rare neonatal benign tumor with an estimated incidence of 1 in 3000 among primary bone tumors, and 1 in one million in the general population. Traditionally, the treatment of choice was an en bloc resection, but surgery limited to symptomatic cases, is now suggested by most authors due to the numerous cases of spontaneous regressions. We report 2 patients of symptomatic MHCW, characterized by progressive respiratory distress, who underwent surgical treatment with prompt resolution of symptoms. Surgeons and neonatologists should be aware of this rare condition and its possible fatal or nearly-fatal complications.”
“Background: The objective of this research was to examine treatment patterns and health-care costs associated with second-step pharmacotherapy in patients with major depressive disorder (MDD) who initiated monotherapy with a selective serotonin reuptake inhibitor (SSRI) in 2010.